Safety and Efficacy of ARQ-154 Foam in Adolescent and Adult Subjects With Scalp and Body Psoriasis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Berk, MD
Arcutis Biotherapeutics
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
47 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arcutis Biotherapeutics Clinical Site 51
Kogarah, New South Wales, Australia
- Arcutis Biotherapeutics Clinical Site 52
Westmead, New South Wales, Australia
- Arcutis Biotherapeutics Clinical Site 54
Hectorville, South Australia, Australia
- Arcutis Biotherapeutics Clinical Site 50
East Melbourne, Victoria, Australia
- Arcutis Biotherapeutics Clinical Site 11
Pleven, Bulgaria
- Arcutis Biotherapeutics Clinical Site 13
Sevlievo, Bulgaria
- Arcutis Biotherapeutics Clinical Site 10
Sofia, Bulgaria
- Arcutis Biotherapeutics Clinical Site 14
Sofia, Bulgaria
- Arcutis Biotherapeutics Clinical Site 12
Stara Zagora, Bulgaria
- Arcutis Biotherapeutics Clinical Site 64
Calgary, Alberta, Canada
- Arcutis Biotherapeutics Clinical Site 61
Barrie, Ontario, Canada
- Arcutis Biotherapeutics Clinical Site 60
London, Ontario, Canada
- Arcutis Biotherapeutics Clinical Site 62
Peterborough, Ontario, Canada
- Arcutis Biotherapeutics Clinical Site 63
Waterloo, Ontario, Canada
- Arcutis Biotherapeutics Clinical Site 66
Montreal, Quebec, Canada
- Arcutis Biotherapeutics Clinical Site 65
Westmount, Quebec, Canada
- Arcutis Biotherapeutics Clinical Site 71
Rogers, Arkansas, United States
- Arcutis Biotherapeutics Clinical Site 72
Fremont, California, United States
- Arcutis Biotherapeutics Clinical Site 85
San Diego, California, United States
- Arcutis Biotherapeutics Clinical Site 21
Cromwell, Connecticut, United States
- Arcutis Biotherapeutics Clinical Site 91
Boynton Beach, Florida, United States
- Arcutis Biotherapeutics Clinical Site 20
Coral Gables, Florida, United States
- Arcutis Biotherapeutics Clinical Site 88
Miami, Florida, United States
- Arcutis Biotherapeutics Clinical Site 90
Miami, Florida, United States
- Arcutis Biotherapeutics Clinical Site 83
Sweetwater, Florida, United States
- Arcutis Biotherapeutics Clinical Site 99
Rolling Meadows, Illinois, United States
- Arcutis Biotherapeutics Clinical Site 78
Indianapolis, Indiana, United States
- Arcutis Biotherapeutics Clinical Site 95
Plainfield, Indiana, United States
- Arcutis Biotherapeutics Clinical Site 77
Louisville, Kentucky, United States
- Arcutis Biotherapeutics Clinical Site 79
Covington, Louisiana, United States
- Arcutis Biotherapeutics Clinical Site 94
Metairie, Louisiana, United States
- Arcutis Biotherapeutics Clinical Site 73
Fridley, Minnesota, United States
- Arcutis Biotherapeutics Clinical Site 84
Saint Joseph, Missouri, United States
- Arcutis Biotherapeutics Clinical Site 98
Portsmouth, New Hampshire, United States
- Arcutis Biotherapeutics Clinical Site 87
High Point, North Carolina, United States
- Arcutis Biotherapeutics Clinical Site 96
Bexley, Ohio, United States
- Arcutis Biotherapeutics Clinical Site 82
Portland, Oregon, United States
- Arcutis Biotherapeutics Clinical Site 80
Broomall, Pennsylvania, United States
- Arcutis Biotherapeutics Clinical Site 97
Murfreesboro, Tennessee, United States
- Arcutis Biotherapeutics Site 70
Arlington, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 Jan 2020
- Primary completion
- 23 Sept 2020
- Completion
- 25 Sept 2020
- Last update posted
- 26 Oct 2022
- Registered enrollment
- 304
- Registry id
- NCT04128007
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.